The University of Chicago Header Logo

Connection

Sandeep Gurbuxani to Janus Kinase 2

Back to Details
This is a "connection" page, showing publications Sandeep Gurbuxani has written about Janus Kinase 2.
Sandeep Gurbuxani
Connection Strength
0.104
Janus Kinase 2
  1. Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial. Clin Cancer Res. 2019 Aug 15; 25(16):4898-4906.
    View in: PubMed
    Score: 0.042
  2. Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition. Nat Med. 2015 Dec; 21(12):1473-80.
    View in: PubMed
    Score: 0.033
  3. AKT is a therapeutic target in myeloproliferative neoplasms. Leukemia. 2013 Sep; 27(9):1882-90.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.